Isoquercetin ameliorates myocardial infarction throughanti-inflammation and anti-Apoptosis factor and regulating TLR4-NF-B signal pathway

54Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

The aim of the present study was to ineestigate the protectiee mechanisms and identify the effects of isoquercetin on myocardial infarction in a rat model of acute myocardial infarction (AMI). Isoquercetin ameliorated myocardial infarct size, creatine kinase (CK), CK-MB and lactic dehydrogenase actieity and inhibited inflammation, oxidatiee stress and heart cell apoptosis in a rat with AMI. Isoquercetin increased endothelial nitric oxide synthase, reduced inducible nitric oxide synthase leeels and suppressed the Toll-like receptor 4-nuclear factor (TLR4-NF)-B signaling pathway in a rat with AMI. Oeerall, isoquercetin ameliorated AMI through anti-inflammatory and anti-Apoptotic factors, and regulation of the TLR4-NF-B signaling pathway. Isoquercetin may therefore potentially exert a protectiee effect against AMI or other heart diseases.

Cite

CITATION STYLE

APA

Ma, C., Jiang, Y., Zhang, X., Chen, X., Liu, Z., & Tian, X. (2018). Isoquercetin ameliorates myocardial infarction throughanti-inflammation and anti-Apoptosis factor and regulating TLR4-NF-B signal pathway. Molecular Medicine Reports, 17(5), 6675–6680. https://doi.org/10.3892/mmr.2018.8709

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free